M. Geoffrey Parker

Affiliations

  • Director at Perrigo Co Plc (PRGO), 2025-06-17
  • Chief Financial Officer at Allogene Therapeutics Inc. (ALLO), 2025-02-05
  • at Better Therapeutics Inc. (BTTX), 2023-12-20
  • Director at Chemocentryx Inc. (CCXI), 2022-10-24
  • Coo, Cfo And Evp at Tricida Inc. (TCDA), 2022-03-02
  • Director at Genomic Health Inc (GHDX), 2019-11-15
  • Director at Sunesis Pharmaceuticals Inc (SNSS), 2017-06-02
  • Executive Vice President & Cfo at Anacor Pharmaceuticals Inc. (ANAC), 2015-03-23
  • Director at Genoptix Inc (GXDX), 2011-03-02
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PRGO $27.10 3,500 $94,850.00 23,762 2025-05-12 Filing
ALLO $3.60 190 $683.05 819,590 2024-01-30 Filing
BTTX $0.73 685,025 $499,999.75 1,028,055 2023-07-27 Filing
PRGO $33.06 10,000 $330,637.00 25,879 2023-06-13 Filing
BTTX $0.83 303,030 $249,999.75 343,030 2023-04-10 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ALLO $1.73 4,361 $7,544.53 1,301,540 2025-02-03 Filing
CCXI $55.89 13,330 $744,973.71 12,690 2021-03-05 Filing
CCXI $56.78 16,670 $946,494.26 26,020 2021-03-05 Filing
CCXI $60.20 1,910 $114,980.47 42,690 2021-03-04 Filing
CCXI $38.21 860 $32,863.01 49,600 2020-03-23 Filing